LDS/Medical Tests/Coagulation Factor VIII Inhibitor Screen, Plasma

Coagulation Factor VIII Inhibitor Screen, Plasma

Factor VIII is one of the many constituents of the coagulation system, and is necessary for proper coagulation. It serves as a cofactor with Factor IXa, as well as forming a complex with Von Willebrand protein. Decreased levels of factor VIII are seen in hemophilia A, a hereditary bleeding disorder. The factor VIII assay measures activity of factor VIII. For normal clotting to occur, factor VIII levels need to be at 25% activity. Hemophilia is defined based on the percent activity: severe (<1%), moderate (1 – 5%), and mild (>5%). Factor VIII deficiency can be distinguished from factor VIII inhibitor by an inhibitor screen. Factor VIII assays are used to guide replacement therapy in patients with hemophilia. Currently, the only therapy for this hereditary disease is lifelong administration of a Factor VIII product.
  • Diagnosis of hemophilia A
  • Diagnosis of Von Willebrand disease
  • As an aid in diagnosis of factor IX deficiency (hemophilia B)
  • As an aid in diagnosis of Disseminated Intravascular Coagulation (DIC)
  • Monitoring and management of hemophilia A
  • Monitoring and management of Von Willebrand disease
  • As an aid in diagnosis of other thrombophilic and bleeding disorders

Increased in:

  • Some inflammatory processes
  • Pregnancy
  • Patient treated with recombinant factor VIII
  • Oral contraceptives

Decreased in:

  • Hemophilia A
  • von Willebrand disease
  • Disseminated intravascular coagulation (DIC)
  • Some other bleeding disorders
  • Myeloproliferative disorders
  • Lymphoproliferative disorders
  • Factor VIII inhibitors

Mild hemophilia A: 5 - 5-% factor VIII activity

Moderate hemophilia A: 1 - 5% factor VIII activity

Severe hemophilia A: < 1% factor VIII activity


 

 

Activated partial thromboplastin time (APTT) method using patient plasma and a factor VIII deficient plama mixture and measuring time to clot is measured optically.

Whole Blood EDTA (Lavender). 

Stability

  • Ambient: 8 days
  • Refrigerated: 8 days
CBC with Platelet Count, Prothrombin Time, Partial Thromboplastin Time, Fibrinogen, Factor VIII Activity Level, Von Willebrand factor, Factor VIII Genetic Testing, Mixing Studies.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login